NCT04558528View on ClinicalTrials.gov

Innovation Platform

CompletedOBSERVATIONAL
Enrollment

640

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Malaria
Interventions
DIAGNOSTIC_TEST

Novel in vitro diagnostics and medical applications

Novel in vitro diagnostics and medical applications

Trial Locations (2)

10430

Eijkman Institute for Molecular Biology, Jakarta

KG622

Stansile, Kigali

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT04558528 - Innovation Platform | Biotech Hunter | Biotech Hunter